XIO

xWire

Posts from every feed QUEST has found across the web — blogs, news, podcasts, channels and more.

The 10 Latest Health Care Articles

FTC Issues Price Transparency Warning to Hospitals

This post was co-authored by Aarathi Kallur, Legal Intern in Robinson+Cole’s Health Law Group. On October 5, 2026, the Federal Trade Commission (FTC) Chairman sent a warning letter to 24 of the country’s largest health care organizations, and published an anonymized version of the letter, reminding the organizations of their ongoing obligation to “provide patients with timely, accurate, and complete pricing” information related to the receipt of health care services. The FTC letter warns that…

Client Alert: Proposed Changes to Behavioral Health Service Rules: Key Changes for Ohio Providers to Review

The Ohio Department of Behavioral Health (DBH) recently proposed numerous changes to Ohio Administrative Code (OAC) Chapter 5122-29, which governs the behavioral health services that DBH-certified providers may provide. The proposed rule changes would rescind and replace several existing rules, amend others, and create a new service category and rule for adult crisis services. The existing rules summarized below (OAC 5122-29-03 through 5122-29-29) are currently under Common Sense Initiative…

This Week in 340B: October 13 – 19, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Issues at Stake: Contract Pharmacy; Other In a case challenging HRSA’s denial of a hospital’s request for retroactive 340B Disproportionate Share Hospital status, the federal government…

Massachusetts Appeals Court Affirms Chapter 93A Liability for Delayed Disability Insurance Benefits

In Constantino v. Paul Revere Life Insurance Co., the Massachusetts Appeals Court, in a non-binding decision under Rule 23.0, affirmed a judgment finding that an insurer violated G. L. c. 93A and G. L. c. 176D by unreasonably delaying disability benefits. The plaintiff sought presumptive total disability benefits under a policy provision covering the total and irrecoverable loss of use of both feet. Although medical evidence submitted described his feet as paralyzed and functionally useless,…

Ohio Department of Medicaid Proposes New Provider Suspension Rules as Centers for Medicare & Medicaid Services Escalates Its Anti-Fraud Push

Amidst heightened federal scrutiny of Medicaid fraud, waste, and abuse, the Ohio Department of Medicaid (ODM) recently proposed two new rules governing the suspension of Medicaid provider agreements and the suspension of claims payments. Ohio Administrative Code (OAC) 5160-1-17.5 replaces the current suspension rule, and OAC 5160-1-17.51 replaces the emergency rule ODM adopted on June 2, 2026. Federal Context: Centers for Medicare & Medicaid Services (CMS) Targets a Sharp Rise in Suspensions…

You’ve Been Sued: A Physician’s Guide to Responding to a Malpractice Claim

Being served with a malpractice lawsuit is unsettling for any physician. What physicians do in the first few days can determine whether they are fully protected or left exposed. No physician expects to receive a letter from a patient’s lawyer putting a physician on notice of an alleged medical malpractice claim. But it happens, and when it does, the steps you take immediately afterward matter more than most physicians realize. The single most important thing you can do is notify your…

A More Unified Path to Self-Disclosure: DOJ and HHS-OIG Harmonize Health Care Fraud Policies

On October 15, 2026, the U.S. Department of Justice (DOJ) and the Department of Health and Human Services Office of Inspector General (HHS-OIG) announced a joint policy aligning their approaches to voluntary self-disclosures of potential criminal health care fraud. Under the new policy, a company that voluntarily self-discloses such conduct to DOJ’s National Fraud Enforcement Division, Health Care Fraud Section, will receive the benefits of both DOJ’s Corporate Enforcement and Voluntary…

Ready to Respond: What Employers Should Know About OSHA's New Opioid Guidance

Introduction On 24 September 2026, the US Department of Labor’s (Department) Occupational Safety and Health Administration (OSHA) issued a new fact sheet, “Opioid Overdose Rescue with Reversal Medications” (Fact Sheet),1 addressing how employers and workers can prepare for and respond to opioid overdoses in the workplace. Although the Fact Sheet is informational and does not impose new compliance requirements, it provides employers with a timely framework for evaluating workplace overdose…

DOJ’s Fraud Division and HHS-OIG Streamline Self-Disclosure of Criminal Healthcare Fraud

Highlights On Oct. 15, the U.S. Department of Justice’s (DOJ) National Fraud Enforcement Division (NFED or Fraud Division) and the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) issued a joint policy (Policy) clarifying that a company voluntarily self-disclosing potential criminal healthcare conduct need only disclose to the NFED to receive the benefits of both DOJ’s Corporate Enforcement and Voluntary Self-Disclosure Policy (CEP) and HHS-OIG’s Health Care…

GLOBE and MFN Pricing: Implications for Cross-Border Drug Development and Transactions

On Oct. 2, 2026, the Centers for Medicare & Medicaid Services (CMS) published the final rule for the Global Benchmark for Efficient Drug Pricing (GLOBE) Model. GLOBE is a mandatory Medicare Part B most-favored-nation (MFN) pricing model that uses international pricing benchmarks to calculate manufacturer rebates for qualifying drugs. While the final rule narrows product eligibility, potentially affected manufacturers face reporting decisions before the performance period begins. This GT Alert…

FinCEN Targets $17.5 Billion in Suspected Health Care Fraud

On September 9, 2026, the U.S. Department of the Treasury announced that its Financial Crimes Enforcement Network (“FinCEN”) has identified approximately $17.5 billion in suspicious financial activity potentially linked to health care fraud. The announcement accompanied the release of a new Financial Trend Analysis (“FTA”), which analyzed over 5,700 Bank Secrecy Act (“BSA”) reports filed by financial institutions between March 1, 2025 and February 28, 2026. The FTA is FinCEN’s second health…

CMS Receives Its Exclusion Authority: What Happens Now?

On October 14, 2026, U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., published a notice (the “Publication”) in the Federal Register formalizing the delegation to the administrator of the Centers for Medicare & Medicaid Services (CMS) of the power to exclude individuals and entities, including providers, from participation in federally funded health care programs—effective immediately. The Publication follows the Secretary’s July 21, 2026, announcement that…

CONGRATULATIONS, YOU’RE A HEALTH COMPANY NOW.

Consumer Health Data Laws Reach Lenders, Carriers, and Software Platforms That Never Saw Themselves Becoming Here is the uncomfortable part, stated first. You do not have to sell medicine, run a clinic, or employ a single physician to fall under the growing body of consumer health data laws. The statutory definitions do the work, and they reach a mortgage lender’s rate-quote page, a wireless carrier’s location logs, and a productivity app that includes a meditation timer. Washington’s version…

This Week in 340B: October 6 – 12, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker. Issues at Stake: Contract Pharmacy; Rebate…

HazCom’s November 20 Deadline: What Employers Still Have Time to Fix

Any employer whose workforce handles hazardous chemicals has a hard date on the calendar: November 20, 2026. That is when the employer-facing obligations of OSHA’s overhauled Hazard Communication Standard, 29 C.F.R. § 1910.1200, come due for chemical substances. The overhaul itself dates to May 2024, when OSHA conformed the rule to Revision 7 of the UN’s Globally Harmonized System, and the agency pushed the employer deadline back roughly four months in a January 2026 final rule so it could…

Virginia Expands Non-Compete Restrictions in 2026

Enforcing non-compete agreements became more complex in Virginia as two amendments to Virginia’s non-compete statute took effect July 1, 2026. One requires severance or other pay for a non-compete to be enforceable when the employee’s employment is terminated without cause. The second prohibits employment non-competes with certain health care professionals. Both changes operate alongside the 2025 expansion of Virginia’s protections for “low-wage employees.” Virginia employers using non-competes…

Wage + Hour Compliance in Healthcare: Particular Problems, Practical Solutions [Video]

Details October 15, 2026 Recent federal and state requirements are creating compliance pitfalls and costly exposure around worker classification, timekeeping, meal break deductions and travel time. Drawing on their experience advising healthcare organizations, Jackson Lewis Wage and Hour Group Co-Chair Justin Barnes and his colleague Andrew Bellwoar offer practical guidance for evaluating pay practices, strengthening recordkeeping and reducing risk. Transcript Justin Barnes Office Managing…

Mental Health Parity Under the Trump Administration: Where DOL Is Headed and What Congress Is Doing About It

On September 8, 2026, the U.S. Department of Labor's Employee Benefits Security Administration (EBSA) issued Field Assistance Bulletin No. 2026-03 (Bulletin 2026-03), narrowing near-term enforcement of the Mental Health Parity and Addiction Equity Act (MHPAEA) to three priority areas and confirming nonenforcement of the 2024 Final Rule's newer provisions pending litigation. The administration has also stopped defending that rule in court and promised a substantially revised proposal by December…

FDA Plans Measures to Mitigate and Prevent Cyclospora Outbreaks

Earlier this month FDA announced ten planned activities to mitigate and prevent future Cyclospora outbreaks. The announcement coincides with the conclusion of the investigation of a multistate outbreak of Cyclospora infections linked to iceberg lettuce. The activities include the planned publication of an outbreak investigation report regarding the recent Cyclospora outbreak in iceberg lettuce, which will include factors contributing to the contamination and recommendations to prevent future…